Pilar M Dominguez

7PUBLICATIONS
49CO-AUTHORS
Innate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical biochemistry - proteins and peptides (incl. medical proteomics)Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 07, 2026
Epigenetic remodeling via HDAC6 inhibition amplifies anti-tumoral immune responses in myeloid leukemia cells.

Julian Schliehe-Diecks, Jia-Wey Tu, Pawel Stachura

|Nov 19, 2025
[Combining epigenetics and immunotherapy: an innovative strategy for acute myeloid leukemia treatment].

Nicole Ballan, Melvin Bordji, Maëna Degoul

|May 06, 2022
Inhibition of pyrimidine biosynthesis targets protein translation in acute myeloid leukemia.

Joan So, Alexander C Lewis, Lorey K Smith

|Mar 21, 2022
Epigenetic Activation of Plasmacytoid DCs Drives IFNAR-Dependent Therapeutic Differentiation of AML.

Jessica M Salmon, Izabela Todorovski, Kym L Stanley

|Sep 03, 2021
A Histone Deacetylase Inhibitor, Panobinostat, Enhances Chimeric Antigen Receptor T-cell Antitumor Effect Against Pancreatic Cancer.

Aesha I Ali, Minyu Wang, Bianca von Scheidt

|May 15, 2021
CDK4/6 Inhibition Promotes Antitumor Immunity through the Induction of T-cell Memory.

Emily J Lelliott, Isabella Y Kong, Magnus Zethoven

Pageof 2

Frequent Collaborators

2 joint publications

Simon J Hogg

2 joint publications

Ricky W Johnstone

2 joint publications

Stefanie Scheu

2 joint publications

Lev M Kats